Risky vs rapid growth in infancy: refining pediatric screening for childhood overweight

Darcy E Gungor1, Ian M Paul, Leann L Birch

  • 1Department of Nutritional Sciences, The Pennsylvania State University, University Park, PA 16802, USA.

Insights

Infant weight gain of 8.15 kg or more from 0-24 months can predict childhood overweight. Refinements using demographics, growth patterns, and feeding choices can improve this screening tool.

Area of Science:

  • Pediatrics
  • Public Health
  • Childhood Obesity

Background:

  • Childhood overweight is a growing public health concern.
  • Early identification of at-risk infants is crucial for intervention.
  • Infant growth patterns are potential indicators of future weight status.

Purpose of the Study:

  • To analyze infant weight gain patterns to identify risks for childhood overweight.
  • To explore additional data from health records to refine infant weight gain as a screening tool.

Main Methods:

  • Retrospective cohort study of 129 children aged 6-8 years.
  • Defined risky infant weight gain using receiver operating characteristic curve analysis.
  • Compared demographic, growth, and feeding differences between at-risk infants who did and did not become overweight.

Main Results:

  • Childhood overweight prevalence was 24.8%.
  • Infants gaining at least 8.15 kg from 0-24 months were at risk.
  • Resilient infants (not overweight) had higher parental education, lower weight gain, longer exclusive breastfeeding, and later introduction of solids.

Conclusions:

  • Infant weight gain of 8.15 kg+ from 0-24 months is a fair, though not widely recognized, screening tool for childhood overweight.
  • Refining the tool with demographic, growth, and feeding data can enhance its predictive accuracy.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Regression Toward the Mean01:52

Regression Toward the Mean

Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when researchers try to extrapolate results...